Mobile application management platform, Hansel.io, has secured US$1.35 million in a funding round led by IDG Ventures with participation from existing backer Endiya Partners, the company said in a statement on Wednesday.

“What made us excited about Hansel.io was the ease with which the product can help mobile developers solve major production issues at runtime. At a time when customer acquisition and retention costs continue to skyrocket, a product like Hansel.io comes as a big boon for a great end-user experience,” Venkatesh Peddi, the Executive Director at IDG Ventures said.

With the latest proceeds, the Bengaluru-based firm will use the funds for team expansion, product development, and growth in overseas markets – that is specifically the expansion of the company presence in the North American market.

This round follows Hansel.io seed funding in February 2016 from Endiya Partners, Tracxn Labs, along with a group of angel investors including Rajesh Sawhney and Mekin Maheshwari.

“With this round of funding, the focus will be to go global, go cross-platform, and help mobile developers be as responsive to their end users as possible,” the co-founder and CEO Varun Ramamurthy explains.

Founded in 2015 by former Flipkart employees – Varun Ramamurthy, Parminder Singh, and Mudit Maur, Hansel Software Pvt. Ltd. develops crash analytics for mobile applications, offering a developer-friendly toolkit that helps them to diagnose, resolve and communicate customer issues on their application.

In other words, Hansel.io allows mobile developers to fix bugs, update configurations, edit user interfaces, and manage security policies of mobile apps at runtime. The platform is currently available on both Android and iOS.

“Despite the abundance of use cases the product provides for, for the developer, it is a simple configure-and-deploy product, where companies can go live in less than 15 minutes. We have built the product to be as intuitive and effortless to use as possible,” said Parminder Singh, one of the co-founders of Hansel.

Hansel.io can help developers start managing their live apps at runtime, with just a five-minute integration process and no code change required, developers can start managing their live apps at runtime using Hansel.

The company claims that it currently has an installed app count of more than 140 million across client such as redBus.in, Toppr, nearbuy, Voonik and ShopX among others. The firm also claims that it has impacted nearly 20 million devices, helping the users by fixing a bug, changing the UI or security permissions.

By Vivian Foo, Unicorn Media

Tokyo-based Cykinso, which develops and sells Mykinso – a test kit for intestinal flora, has announced that it has secured 270 million yen (about US$2.3 million) from the Regional Health Care Industry Support Fund and other investors in its seed round.

The GP for the Regional Health Care Industry Support Fund are REVIC Capital and AGS Consulting under the jurisdiction of the Regional Economic Revitalization Support Organization, with banks being the funds’ limited partners (LPs).

This fund follows an earlier round of angel funding from individual investors and grants secured from numerous government agencies such as the Ministry of Economy, Trade, and Industry’s “Project to Encourage the Creation of SMEs and New Business” as well as a grant from Kanagawa Prefecture for the “Project to Promote the Creation of the Preventive Medicine market”.

Despite being grants, Cykinso has, in terms of business stages, labeled the proceeds received as their seed round, making their most recent funding essentially a series A round.

According to Cykinso. these latest proceeds will be used to finance business development, including using the data collected from the intestinal flora tests to develop a system for offering nutritional guidance. This platform will focus on gut microbiomes is unique, given the crucial role and impact it has on an individuals’ health.

Founded in November 2014 by CEO Yu Sawai, who has previously worked at a genome research company, the venture is conducting joint research with RIKEN Innovation Center’s Benno Laboratory and Osaka University’s Research Institute for Microbial Diseases’ Department of Infectious Metagenomics.

In August 2015, the Japanese startup was accredited as a RIKEN Certified Venture. Three months later, the firm released “Mykinso” – a home-testing kit for intestinal flora which allows people to test the state of their intestinal bacteria (i.e. gut biome).

Following this, there is also the release of “Mykinso Pro” for the professional market which enables medical institutions and clinics to register patient examination data and manage specimens. Data provided will be presented to the user or the user’s doctor in the form of a cloud or paper report.

The company claims that it has collected intestinal flora data from around 2000 people through both services, receiving permission from users beforehand and the assurance that users will remain anonymous. Depending on the scale of the accumulated data regarding intestinal floral, the services to be offered and the business stage will be adjusted accordingly.

In October 2016, Cykinso has along with dispensing pharmacy big name Aisei Pharmacy (TSE:3170) and leading mobile service provider MTI (TSE:9438) held an event called “Intestinal Summit” to promote awareness among general consumers about intestinal flora and services.

Additionally, this week the Japanese startup will move offices from the Kanagawa Science Park, where they have resided for the two years since inception, to the Good Morning Building in Shibuya, Tokyo. For Cykinso this signifies its transformation from a purely academic venture into the business domain.

By Vivian Foo, Unicorn Media